Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Payables (2016 - 2025)

Bruker (BRKR) has disclosed Payables for 16 consecutive years, with $227.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 2.86% year-over-year to $227.4 million, compared with a TTM value of $227.4 million through Dec 2025, down 2.86%, and an annual FY2025 reading of $227.4 million, down 2.86% over the prior year.
  • Payables was $227.4 million for Q4 2025 at Bruker, up from $184.4 million in the prior quarter.
  • Across five years, Payables topped out at $244.6 million in Q1 2025 and bottomed at $141.1 million in Q3 2021.
  • Average Payables over 5 years is $189.3 million, with a median of $186.6 million recorded in 2023.
  • The sharpest move saw Payables grew 25.34% in 2024, then dropped 18.95% in 2025.
  • Year by year, Payables stood at $147.4 million in 2021, then grew by 21.03% to $178.4 million in 2022, then rose by 13.62% to $202.7 million in 2023, then increased by 15.49% to $234.1 million in 2024, then fell by 2.86% to $227.4 million in 2025.
  • Business Quant data shows Payables for BRKR at $227.4 million in Q4 2025, $184.4 million in Q3 2025, and $243.0 million in Q2 2025.